Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds
|
journal
|
April 2002 |
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
|
journal
|
March 2022 |
Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination
|
journal
|
October 2021 |
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
|
journal
|
July 1977 |
Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
|
journal
|
November 2016 |
General mechanism for modulating immunoglobulin effector function
|
journal
|
May 2013 |
A Multilaboratory Comparison of Calibration Accuracy and the Performance of External References in Analytical Ultracentrifugation
|
journal
|
May 2015 |
The Immunoregulatory Roles of Antibody Glycosylation
|
journal
|
May 2017 |
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
|
journal
|
February 2010 |
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose
|
journal
|
July 2011 |
Fc Glycan-Mediated Regulation of Placental Antibody Transfer
|
journal
|
June 2019 |
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
|
journal
|
April 2008 |
Tools for mammalian glycoscience research
|
journal
|
July 2022 |
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
|
journal
|
October 2016 |
Synthetic nanobodies as angiotensin receptor blockers
|
journal
|
August 2020 |
Antibody fucosylation predicts disease severity in secondary dengue infection
|
journal
|
June 2021 |
Highly accurate protein structure prediction with AlphaFold
|
journal
|
July 2021 |
A single glycan on IgE is indispensable for initiation of anaphylaxis
|
journal
|
March 2015 |
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
|
journal
|
October 2017 |
In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody
|
journal
|
October 1979 |
Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor
|
journal
|
October 2012 |
Revisiting the Role of Glycosylation in the Structure of Human IgG Fc
|
journal
|
June 2012 |
The bovine antibody repertoire
|
journal
|
January 2006 |
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
|
journal
|
November 2020 |
Synthetic nanobodies as tools to distinguish IgG Fc glycoforms
|
journal
|
November 2022 |
Coevolved Canonical Loops Conformations of Single-Domain Antibodies: A Tale of Three Pockets Playing Musical Chairs
|
journal
|
June 2022 |
Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease
|
journal
|
February 2010 |
Type I and type II Fc receptors regulate innate and adaptive immunity
|
journal
|
July 2014 |
Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection
|
journal
|
October 2020 |
Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa
|
journal
|
October 2017 |
The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex
|
journal
|
July 2000 |
The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo
|
journal
|
February 2011 |
Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
|
journal
|
August 2017 |
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
|
journal
|
February 2018 |
Association of FcγRIIa Polymorphism with Clinical Outcome of Dengue Infection: First Insight from Pakistan
|
journal
|
October 2015 |
Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database
|
journal
|
May 2016 |
Improved protein structure prediction using potentials from deep learning
|
journal
|
January 2020 |
Sialylation of immunoglobulin E is a determinant of allergic pathogenicity
|
journal
|
May 2020 |
Antibody-dependent enhancement of severe dengue disease in humans
|
journal
|
November 2017 |
Extensive substrate recognition by the streptococcal antibody-degrading enzymes IdeS and EndoS
|
journal
|
December 2022 |
Monoclonal antibody-mediated enhancement of dengue virus infectionin vitroandin vivoand strategies for prevention
|
journal
|
May 2007 |
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
|
journal
|
January 2017 |
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy
|
journal
|
January 2014 |
Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections
|
journal
|
April 2014 |
Application of Lectin Microarrays for Biomarker Discovery
|
journal
|
March 2020 |
Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows
|
journal
|
July 2017 |
FcRn, but not FcγRs, drives maternal-fetal transplacental transport of human IgG antibodies
|
journal
|
May 2020 |
Target protein deglycosylation in living cells by a nanobody-fused split O-GlcNAcase
|
journal
|
March 2021 |
Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection
|
journal
|
October 2015 |
Functional diversification of IgGs through Fc glycosylation
|
journal
|
September 2019 |
Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1
|
journal
|
June 2014 |
Antibody recognition of a unique tumor-specific glycopeptide antigen
|
journal
|
May 2010 |
Modulating IgG effector function by Fc glycan engineering
|
journal
|
March 2017 |
Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial
|
journal
|
December 2016 |
Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors
|
journal
|
December 2008 |
The Carbohydrate at FcγRIIIa Asn-162: AN ELEMENT REQUIRED FOR HIGH AFFINITY BINDING TO NON-FUCOSYLATED IgG GLYCOFORMS
|
journal
|
December 2005 |
Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan
|
journal
|
July 2018 |
Analytical Ultracentrifugation: Sedimentation Velocity and Sedimentation Equilibrium
|
book
|
January 2008 |
Core Fucosylation of IgG B Cell Receptor Is Required for Antigen Recognition and Antibody Production
|
journal
|
February 2015 |
Agalactosylated IgG antibodies depend on cellular Fc receptors for
in vivo
activity
|
journal
|
May 2007 |
Calculating Sedimentation Coefficient Distributions by Direct Modeling of Sedimentation Velocity Concentration Profiles
|
book
|
January 2004 |
Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease
|
journal
|
January 2018 |
FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications
|
journal
|
May 2010 |
Proinflammatory IgG Fc structures in patients with severe COVID-19
|
journal
|
November 2020 |